Skip to main content
. 2012 May 19;1823(11):2029–2037. doi: 10.1016/j.bbamcr.2012.05.014

Fig. 3.

Fig. 3

Molecular structures of selected DUB and Ubl-protease inhibitors characterized by competitive probe labeling; sub-structures with Michael acceptor functionality (capable of conjugate addition to Cys) are highlighted in blue and aryl halides which are capable of nucleophilic aromatic substitution are highlighted in red.